Constraining the expression of nicotinic acetylcholine receptors by using pentameric constructs

被引:35
作者
Groot-Kormelink, PJ [1 ]
Broadbent, S [1 ]
Beato, M [1 ]
Sivilotti, LG [1 ]
机构
[1] UCL, Dept Pharmacol, London, England
基金
英国惠康基金; 英国医学研究理事会;
关键词
D O I
10.1124/mol.105.019356
中图分类号
R9 [药学];
学科分类号
1007 ;
摘要
Much of our understanding of ligand-gated ion channels comes from heterologous expression studies. However, this technique cannot produce receptors with a predetermined subunit composition for channels formed by several different subunits and cannot insert a single mutation copy if the subunit of interest is present in several copies in the channel. Here, we describe a novel approach that overcomes these problems by expressing pentameric constructs, in which the code of the five subunits is linked ( i.e., beta 4_beta 4_alpha 3_beta 4_alpha 3). This is the first time that a concatemer of the complete pentameric receptor has been expressed for channels in the cysteine-loop superfamily. The presence of the linker did not change the agonist or antagonist sensitivity of alpha 3 beta 4 nicotinic receptors. We show evidence that the expressed receptors were made up of alpha 3 and beta 4 subunits in one pentameric fusion protein as designed in the construct. This approach can be applied to any nicotinic superfamily receptor to produce channels with a defined subunit arrangement and to introduce specific mutations at any desired location of the pentameric fusion protein.
引用
收藏
页码:558 / 563
页数:6
相关论文
共 25 条
[21]   Monomeric and dimeric byproducts are the principal functional elements of higher order P2X1 concatamers [J].
Nicke, A ;
Rettinger, J ;
Schmalzing, G .
MOLECULAR PHARMACOLOGY, 2003, 63 (01) :243-252
[22]   Contribution of individual subunits to the multimeric P2X2 receptor:: Estimates based on methanethiosulfonate block at T336C [J].
Stoop, R ;
Thomas, S ;
Rassendren, F ;
Kawashima, E ;
Buell, G ;
Surprenant, A ;
North, RA .
MOLECULAR PHARMACOLOGY, 1999, 56 (05) :973-981
[23]   GABA-A receptor subtypes in the brain: a paradigm for CNS drug discovery? [J].
Whiting, PJ .
DRUG DISCOVERY TODAY, 2003, 8 (10) :445-450
[24]  
Zhou Y, 2003, J NEUROSCI, V23, P9004
[25]   Four pharmacologically distinct subtypes of α4β2 nicotinic acetylcholine receptor expressed in Xenopus laevis oocytes [J].
Zwart, R ;
Vijverberg, HPM .
MOLECULAR PHARMACOLOGY, 1998, 54 (06) :1124-1131